Pharmacyclics (PCYC) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents
Marketable securities
Accounts receivable
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Other assets
Total assets
Accounts payable
Accrued liabilities
Deferred revenue
Total current liabilities
Deferred rent
Total liabilities
Preferred stock, $0.0001 par value; 1,000,000 shares authorized at September 30 and June 30, 2011; no shares issued and outstanding
Common stock, $0.0001 par value; 100,000,000 authorized at September 30 and June 30, 2011; shares issued and outstanding - 68,538,744 and 67,915,865 at September 30 and June 30, 2011
Additional paid-in capital
Accumulated other comprehensive income
Deficit accumulated during development stage
Total stockholders' equity
Total liabilities and stockholders' equity

Entities mentioned with PCYC

View All Entities